Evidence map›Paper›PMID 42206741›Full record

ArticleClinical genetics2026

Novel Postzygotic Variants Associated With Hypomelanosis of Ito Expand the ACTB-Related Neurocutaneous Disease Spectrum.

Estella Castillon, Paul Rollier, Didier Bessis, Laurent Pasquier, Caroline Racine, Alexis Praga, Pierre Vabres, Bertille Bonniaud, Paul Kuentz, Laurence Faivre

Abstract readCase Reports
In one paragraph

Article in Clinical genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Estella CastillonUniversité Bourgogne Europe, Inserm, CTM UMR1231, Equipe GAD, FHU TRANSLAD, Centre de Génétique, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Référence Déficiences Intellectuelles de Causes Rares, Dijon, France.ORCID https://orcid.org/0009-0006-5904-9847
Paul RollierUniv Rennes, CHU Rennes (Centre de Référence Anomalies du Développement et Syndromes Malformatifs), CNRS, IGDR-UMR6290, Rennes, France.ORCID https://orcid.org/0000-0001-7303-8825
Didier BessisService de Dermatologie, Centre de Référence Des Maladies Rares de la Peau et Des Muqueuses D'origine Génétique, CHU Montpellier, Montpellier, France.
Laurent PasquierUniv Rennes, CHU Rennes (Centre de référence Déficiences Intellectuelles de Causes Rares), CNRS, ARENES-UMR 6051, Rennes, France.
Caroline RacineUniversité Bourgogne Europe, Inserm, CTM UMR1231, Equipe GAD, FHU TRANSLAD, Centre de Génétique, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Référence Déficiences Intellectuelles de Causes Rares, Dijon, France.ORCID https://orcid.org/0000-0003-2378-5982
Alexis PragaUniversité Marie et Louis Pasteur, CHU Besançon Franche-Comté, Oncobiologie Génétique Bioinformatique, FHU TRANSLAD, Besançon, France.
Pierre VabresUniversité Bourgogne Europe, CHU Dijon Bourgogne, Centre de Référence Des Maladies Rares de la Peau et Des Muqueuses D'origine Génétique MAGEC, Dijon, France.
Bertille BonniaudUniversité Bourgogne Europe, CHU Dijon Bourgogne, Centre de Référence Des Maladies Rares de la Peau et Des Muqueuses D'origine Génétique MAGEC, Dijon, France.
Paul KuentzUniversité Marie et Louis Pasteur, CHU Besançon Franche-Comté, Oncobiologie Génétique Bioinformatique, FHU TRANSLAD, Besançon, France.ORCID https://orcid.org/0000-0003-2814-6303
Laurence FaivreUniversité Bourgogne Europe, Inserm, CTM UMR1231, Equipe GAD, FHU TRANSLAD, Centre de Génétique, Centre de Référence Anomalies du Développement et Syndromes Malformatifs, Centre de Référence Déficiences Intellectuelles de Causes Rares, Dijon, France.ORCID https://orcid.org/0000-0001-9770-444X

Funding

European Union
6 · The paper itself

Abstract

Several clinical entities are associated with ACTB pathogenic variants. Most notably, constitutional missense gain-of-function variants are linked to Baraitser-Winter cerebrofrontofacial syndrome, and recurrent somatic gain-of-function Arg147 variants are reported in Becker's nevus or in smooth muscle hamartomas. We describe three individuals with mosaic hypopigmentation following Blaschko's lines, associated or not with neurodevelopmental features, with postzygotic ACTB variants identified with deep next-generation sequencing on skin biopsy from an affected area. We identified the same missense p.(Arg335His) variant in individuals #1 and #3, already reported in a constitutional state in a fetus. Individual #2 carried an unreported in-frame insertion-deletion (p.(Ser348_Leu349insPheHisLeuProProSerIle)). Thus, we describe a previously unreported phenotype related to postzygotic ACTB variants with hypopigmentation associated or not with neurodevelopmental features, distinct from Becker presentations, bridging constitutional neurodevelopmental and somatic cutaneous phenotypes.

Indexed as

Genetic Predisposition to DiseaseHypopigmentationNeurocutaneous SyndromesChildChild, PreschoolFemaleHigh-Throughput Nucleotide SequencingHumansMaleMosaicismPhenotypeACTBBlaschko's linesdeep next‐generation sequencinghypomelanosis of Itohypopigmentationneurocutaneous phenotypepigmentary mosaicism

Identifiers

PMID42206741
PMCPMC13431713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.